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Azidothymidine (AZT) and AZT monophosphate (AZT-MP) in concentrations as low as 10 and 50 AM, respectively, promote oxidation of
chemically deacetylated 2V,7V-dichlorodihydrofluorescein (DCDHF) to 2V,7V-dichlorofluorescein (DCF) by rat peritoneal macrophages activated
with latex. Cells were incubated with AZTandAZT-MP for 18 h, washed out from residual AZTor AZT-MP and activatedwith latex for 30 or 60
min in the presence of DCDHF. Latex-activated cells oxidize DCDHF extracellularly due to release of hydrogen peroxide and low-molecular
iron complexes, which is verified using catalase, desferal and the peroxidase inhibitor sodium azide. AZT and AZT-MP increase DCDHF
oxidation due to additional release of hydrogen peroxide as demonstrated by catalase inhibition of DCDHF oxidation and direct H2O2
measurement. Thymidine and thymidine phosphates did not show any effect on macrophage activation. In separate experiments we evaluated
the in vitro prooxidant activity of AZT, AZT-MP, AZT triphosphate (AZT-TP), AZT glucuronide (GAZT) and 3V-amino-3V-deoxythymidine
(AMT) in a cell-free system using the hydrogen peroxide-iron-mediated oxidation of DCDHF. Under these conditions, AZT and AZT
phosphates exhibit a prooxidant effect in concentrations as low as 100 AM. Furthermore, GAZT is a less effective prooxidant and AMTacts like
an antioxidant. Thymidine did not show any effect.
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induced mitochondrial myopathy [1–3], bone marrow
toxicity [4] and transplacental genotoxicity and tumori-
genicity [5]. Some toxic effects of the drug have been
linked to its ability to generate free radicals [2,6,7]. For
example, AZT has been shown to suppress mitochondrial
manganese superoxide dismutase (Mn-SOD), causing an
increase in carbonyl proteins and a decrease of sulfhy-
dryl content in tissues [8]. Furthermore, AZT can induce
oxidative DNA damage [1,9] and lipid peroxidation [2].
Vitamins C and E, accordingly, have been shown to
prevent AZT-induced myopathy [1], and zinc and N-
acetylcysteine have been shown to ameliorate hemato-
poietic toxicity of AZT [10].
Dichlorodihydrofluorescein (DCDHF) and dihydro-
rhodamine (DHR) 123 are often being used as indicators
of free radical generation induced by AZT and analogs
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thymidine (Fig. 1A), azidothymidine (zidovudine) (Fig.
1B), as well as structures of AZT metabolites including
azidothymidine monophosphate (AZT-MP; Fig. 1C), 3V-
amino-3V-deoxythymidine (AMT; Fig. 1D) and AZT-h-D-
glucuronide (GAZT; Fig. 1E). Activated macrophages are
one of the important sources of oxidants in vivo; in
addition, these cells play a crucial role in the develop-
ment of HIV infection [13]. In this study, we have
observed that AZT and AZT-MP promote DCDHF oxi-
dation during the respiratory burst in activated rat
peritoneal macrophages. In this case, stimulation of cells
leads to the activation of NADPH oxidase and a subse-
quent release of superoxide anion forming H2O2, which
further decomposes in the presence of peroxidases, or
low-molecular iron complexes released during exocytosis
[14,15]. We have also found a direct prooxidant action
of AZT and its metabolites in a cell-free chemical
system consisting of hydrogen peroxide, iron, and DCDHF.
These findings are important, since NADPH oxidase activa-
tion can occur during secondary infections in HIV patients
[13], although the interactions of AZT and its derivatives
with cells and membranes may be significantly more com-
plex than the above described reactions in an aqueous phase.
Furthermore, redox properties of AZT and its metabolites
may be relevant to other nucleoside analogs (NRTIs) cur-
rently in use in HIV patients, due to the structural similarity
of these drugs.Fig. 1. AZT and AZT derivatives. Molecular structures of thymidine (A), azid
deoxythymidine (AMT) (D) and AZT-h-D-glucuronide (GAZT) (E).2. Materials and methods
2.1. Materials
3V-Azido-3V-deoxythymidine 5V-monophosphate sodium
salt (AZT-MP), 3V-azido-3V-deoxythymidine-h-D- glucuro-
nide sodium salt (GAZT), 3V-amino-3V-deoxythymidine
(AMT), sodium azide (NaN3), 1-(2-deoxy-h-D-ribofurano-
syl) thymine, 2-deoxyribose 5-phosphate sodium salt, 2-
deoxyribose, N-(2-hydroxyethyl) piperazine-NV-(2-ethane-
sulfonic acid) (HEPES), 2V,7V-dichlorofluorescin diacetate
(DCDHF-DA), horseradish peroxidase (HRPO, 269 pur-
purogalin U/mg), phenol red, polystyrene latex beads
(LB), catalase (3940 U/mg protein, from bovine liver),
desferrioxamine mesylate (desferal), dextrose, casein and
hydrogen peroxide were purchased from Sigma (St
Louis, MO); 3V-azido-3V-deoxythymidine (AZT, azidothy-
midine) and 2,4-dihydroxy-5-methylpyrimidine were from
Fluka Biochemika (Switzerland), and 3V-azido-3V-deoxy-
thymidine 5V-triphosphate tetralithium salt (AZT-TP) was
from Calbiochem (La Jolla, CA). Deionized Milli-Q
water (Millipore, Bedford, MA) was additionally treated
using analytical grade chelating resin CHELEX 100
(Bio-Rad, Richmond, CA) prior to use. Calcium- and
magnesium-free Hanks buffered salt solution (HBSS) was
obtained from Biosource International (Camarillo, CA).
LIVE/DEAD cytotoxicity kit was obtained from Molec-
ular Probes (Eugene, OR).othymidine (AZT) (B), AZT-monophosphate (AZT-MP) (C), 3V-amino-3V-
t Biophysica Acta 1688 (2004) 257–264 2592.2. Macrophage isolation
Macrophages were isolated from the peritoneal cavity of
300–400-g male Sprague Dawley rats (Harlan, Indianap-
olis, Indiana) 3 days following i.p. injection of 20 ml of 1%
casein in 0.9% NaCl. Animals were euthanized under deep
ether anesthesia and the peritoneal cavity was washed with
60–80 ml of HBSS. After 3–5 min of gentle shaking of the
abdomen, the resultant peritoneal wash solution was aspi-
rated from the peritoneal cavity and centrifuged at 400 g
for 10 min at 4 jC. Erythrocytes in the cell preparation were
lysed using a 1:2.5 solution of deionized water and HBSS.
Viable cells were counted on a standard hemocytometer as
determined using exclusion of 0.4% trypan blue.
2.3. Respiratory burst assay
The oxidation of 2V,7V-dichlorodihydrofluorescein to
2V,7V-dichlorofluorescein (DCF) was measured with a Cyto-
Fluor series 2350 fluorescent plate reader, using a 24-well
tissue culture plate (Becton Dickinson Labware, NJ, USA).
Stock solutions of DCDHF were prepared by dissolving
DCDHF-DA in 20 mM NaOH at room temperature [16,17].
Diluted solutions of DCDHF were prepared fresh in HBSS
to neutralize residual NaOH prior to adding it to cells.
Aliquots of cells containing 1.0 106 viable macrophages
were incubated under 5% carbon dioxide and 95% air at 37
jC for 2-h. Non-adherent cells were washed from the
culture plate using warm HBSS. The remaining adherent
cells were further incubated under the same conditions for
18 h in the presence and absence of varying concentrations
of AZT and AZT-MP. Residual AZT and AZT-MP were
washed from the cell preparation and DCDHF (5 AM) was
added to cells prior to their activation. The oxidation of
DCDHF to DCF by activated macrophages was determined
by measuring DCF fluorescence immediately (initial fluo-
rescence), 30 and 60 min after the addition of 1 or 10 Al of a
10% suspension of polystyrene LB. All experiments were
performed in the dark at room temperature. The fluores-
cence of DCF was read using excitation and emission filters
of 485 and 530 nm, respectively. The relative changes in
fluorescence units (RFU) were estimated by subtracting the
average initial fluorescence for each subsequent reading for
each treatment.
2.4. Hydrogen peroxide determination
Determination of hydrogen peroxide produced by non-
activated and activated macrophages was based on the
HRPO-mediated oxidation of phenol red [18]. Aliquots of
cells containing 1.0 106 macrophages were added to 24-
well tissue culture plates and incubated under 5% carbon
dioxide and 95% air at 37 jC for 2 h. Non-adherent cells
were washed from the culture plate using warm HBSS. The
attached cells were then incubated for 18 h in the presence
or absence of AZT or AZT-MP, washed with warm HBSS
A.M. Komarov et al. / Biochimica eand placed in a modified HBSS media solution containing
0.28 mM phenol red and 10 U/ml HRPO. In one set of
experiments, the AZT (AZT-MP)-treated cells were further
incubated for an additional 18 h to detect H2O2 generation
in unstimulated cells. In a second series of experiments, the
hydrogen peroxide concentration produced by untreated and
AZT (AZT-MP)-treated LB-activated macrophages (10 Al of
a 10% suspension of polystyrene LB) was determined over a
1-h period of activation. In both experiments, the culture
media was collected, centrifuged for 20 min at 4 jC and
analyzed for changes in hydrogen peroxide concentration
using the standard curve prepared with known concentra-
tions of hydrogen peroxide. Prior to analysis, the pH of each
sample was adjusted by adding 10 Al of 1 N sodium
hydroxide. Changes in absorbance were measured at 610
nm using a Beckman DU 650 spectrometer versus a blank
sample containing an equal volume of modified HBSS
media solution and sodium hydroxide.
2.5. Dichlorofluorescin procedure in a cell-free system
The redox properties of AZT, AZT-MP, AZT-TP, AMT,
GAZT, thymidine and its components were measured in
vitro using DCDHF—a hydrolyzed derivative of DCDHF-
DA, described above [16,17]. Small aliquots of the stock
solution were stored in the dark at  20 jC under argon
until use. DCDHF, in the presence of hydrogen peroxide
and iron, forms the fluorescent compound 2V,7V-dichloro-
fluorescein (DCF) [14,15].
All experiments were performed in the dark at room
temperature. Measurements were carried out in a 3-ml
cuvette of 100 mM phosphate-buffered saline (PBS) or
100 mM HEPES buffer (pH = 7.4) containing 50 AM
DCDHF and 2 mM hydrogen peroxide. The reaction was
initiated by adding an aliquot of ferrous sulfate (FeS-
O47H2O) maintained under a constant stream of N2. The
final concentration of FeSO4 was 20 AM. The absorbance of
DCF was detected at 500 nm using a Beckman DU 650
spectrometer and the formation of DCF was measured using
an extinction coefficient of e500 = 59,500. Phosphate buffer
containing 50 AM of DCDHF was used as a blank sample.
Hydrogen peroxide alone or iron sulfate alone did not cause
significant oxidation of DCDHF at room temperature.
2.6. Statistical analysis
All results are expressed as meanF S.E. Statistical differ-
ences between the cell experiments were determined using a
one-way ANOVA. The Tukey test was used to test all
pairwise comparisons of the mean response to each compa-
rable activated non-AZT- or non-AZT-MP-treated cell prep-
aration (control group). Analysis was performed using
statistical analysis software SigmaStat for Windows (Ver-
sion 2.03). Data obtained in a cell-free system are represen-
tative of two to three experiments and three to seven total
determinations. Where applicable, the data were fitted with
A.M. Komarov et al. / Biochimica et Biophysica Acta 1688 (2004) 257–264260an appropriate theoretical nonlinear regression plot generat-
ed using the Jandel graphical software package SigmaPlot
(Version 7.0). The strength of the AZT and AZT-MP dose–
response relationship in promoting DCDHF oxidation was
determined using the PROC REG SAS procedure using PC-
SAS (SAS Institute, Cary, NC) and the statistical signifi-
cance level was set at P < 0.05.3. Results and discussion
3.1. AZT and AZT-MP promote DCDHF oxidation by latex-
activated macrophages
In order to study the effects of AZT and AZT-MP on free
radical generation by activated cells, we have used latex-
activated peritoneal macrophages obtained from casein-
treated rats. DCDHF-DA is being used as an indicator of
free radical generation induced by AZT and analogs [2]. TheFig. 2. Azidothymidine (AZT, A) and azidothymidine monophosphate (AZT-
macrophages, as assessed by the oxidant-sensitive probe DCDHF (5 AM). Macrop
30, or 60 min. Data represent the mean RFUF S.E. of three individual measureme
were pooled for analysis from two animals. (y) P < 0.05 and (§) P < 0.001 versuuse of chemically deacetylated 2V,7V-dichlorodihydrofluor-
escein allows detection of extracellular or intracellular free
radical generation [14,15], although deacetylated fluores-
cent indicator does not penetrate cellular membranes as
readily as DCDHF-DA. Latex-activated cells oxidize
DCDHF due to release of H2O2 and low-molecular iron
complexes, which was verified in experiments using inhib-
itors catalase (1000 U/ml), desferal (100 AM) and peroxi-
dase inhibitor sodium azide (2 mM). Catalase and desferal
partially inhibited oxidation of DCDHF by latex-activated
macrophages, but azide did not have any effect (data not
shown). Hydrogen peroxide alone or iron sulfate alone did
not cause significant oxidation of DCDHF at room temper-
ature. We have performed our cell experiments in HBSS,
which should be comparable to the phosphate buffer used
for the experiments in a cell-free system, described below.
As shown on Fig. 2, we have observed significant and
dose-dependent increases in DCDHF oxidation in cells
incubated 18 h with AZT in concentration ranging fromMP, B) promote free radical generation by LB activated rat peritoneal
hages were activated with 10 Al of a 10% suspension of polystyrene LB for
nts minus the average initial fluorescence for each treatment. Macrophages
s each respective nontreated control group.
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from 200 AM to 1 mM (Fig. 2B). Incubation with AZT did
not have any effect on cell viability as verified using a
LIVE/DEAD cytotoxicity kit. The increased oxidation of
DCDHF was evident after 30 min of cell activation with
latex and it was even more pronounced after 60 min (Fig.
2A and B). The threshold concentrations of AZT and AZT-
MP were between 50 and 100 AM and 50 and 200 AM,
respectively. Furthermore, dose and response correlated
well for AZT at 60 min (r2 = 0.34, P= 0.023) and AZT-
MP (r2 = 0.88, P < 0.001 at 60 min, r2 = 0.87, P < 0.001 at
30 min). The changes in DCDHF oxidation were not
significant for AZT at 0.5 mM; however, the same dose
of AZT-MP produced a significant increase in fluorescence
after 60 min of cell activation with latex (Fig. 2A and B).
Using a lower LB concentration (1 Al of 10% stock
solution per sample), we have observed a significant
increase in DCDHF oxidation at 60 min with cells exposedFig. 3. Effects of azidothymidine (AZT, A) and azidothymidine monophosphat
DCDHF (5 AM). Macrophages were activated with 1 Al of a 10% suspension of po
individual measurements minus the average initial fluorescence for each treatmen
versus each respective nontreated control group.to 50 AM AZT and 10 AM AZT-MP compared to control
cells (Fig. 3A and B). The threshold concentrations of
AZT and AZT-MP were between 10 and 50 AM and less
than 10 AM, respectively. Note that a lower concentration
of LB significantly lowered the activity threshold for both
AZT and AZT-MP. Interestingly, the prooxidant effect of
AZT and AZT-MP was evident in cells washed with HBSS
(thus removing the residual AZT and AZT-MP from the
cell preparation), prior to LB activation; therefore, any
direct effects of AZT and AZT-MP on DCDHF oxidation
(see below) were excluded. Furthermore, acute exposure of
LB-activated cells to AZT did not produce significant
additional oxidation of DCDHF compared to LB-activated
cells without AZT. Thymidine and thymidine phosphates
did not show any effect on cells activation (data not
shown). Catalase (100 U/ml) addition during incubation
of cells with latex (1 Al) removed the effect of 1 mM AZT
(737F 4; n = 4) and AZT-MP (721F 9; n = 4) on DCDHFe (AZT-MP, B) on LB-stimulated rat peritoneal macrophage oxidation of
lystyrene LB for 30 or 60 min. Data represent the mean RFUF S.E. of three
t. Macrophages were pooled for analysis from two animals. (§) P < 0.001
Fig. 4. Direct prooxidant activity of AZT and AZT phosphates.
Concentration-dependent effects of AZT (circle), AZT-MP (diamond),
and AZT-TP (square) on DCDHF oxidation in 100 mM PBS, pH= 7.4 (A;
closed symbols) and 100 mM HEPES buffer, pH= 7.4 (B; open symbols).
Test conditions include 50 AM DCDHF, 2.0 mM H2O2 and 20 AM FeSO4
and the absorbance of the oxidation product DCF is measured at 500 nm.
Relative absorbance is calculated as the ratio in absorbance with and
without AZT, AZT-MP, and AZT-TP, respectively. All values are reported
as meansF S.E. of three to seven separate determinations.
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n = 4).
The release of H2O2 has been reported in mitochondria
isolated from the liver of AZT-treated mice [11]. Therefore,
we have tested the hypothesis that cells incubated with AZT
release more hydrogen peroxide than control cells prior or
after activation with latex. However, the amount of H2O2
released by cells overnight prior to the LB activation was not
significantly different in cells incubated with or without AZT.
Furthermore, while latex activation induced an additional
release of hydrogen peroxide (0.84F 0.12 nmol/million
cells), overnight incubation with 500 AM AZT or AZT-MP
increased H2O2 release from LB-activated cell (1.23F 0.09
and 1.34F 0.42 nmol/million cells, respectively), compared
to cells untreated with AZT. In addition, the possibility that
AZT may mobilize intracellular iron may also explain the
observed increase in DCDHF oxidation by latex-activated
macrophages. Interestingly, macrophages from HIV patients
display higher than normal iron load compared to healthy
volunteers [19,20]. NADPH-oxidase activation is sensitive to
reactive oxygen species (ROS) [21,22] and can be a potential
target for AZT-induced oxidative stress. Note that both AZT
and AZT-MP can penetrate inside the cells [23,24] and affect
enzymes involved in NADPH-oxidase activation. In addi-
tion, the possibility that AZT and AZT-MP could interact
with the external surface of the membrane, either directly
perturbing NADPH-oxidase activity or affecting the barrier
function of the cell membrane, could not be excluded. Hence,
we have tested a direct prooxidant activity of AZT and AZT
derivatives in a cell-free system.
3.2. Direct prooxidant activity of AZT and AZT phosphates
In phosphate buffer AZT, AZT-MP and AZT-TP demon-
strate prooxidant activity in a concentration ranging from
100 AM to 1 mM (Fig. 4A). The prooxidant effect of AZT in
PBS was optimal at pH = 7.4 as compared to pH = 6.0 or
pH = 8.0 (data not shown). For comparison, the prooxidant
activity of AZT and AZT-MP in HEPES buffer (pH = 7.4) is
observed in a concentration ranging from 100 to 400 AM
(Fig. 4B). The difference in redox properties for AZT and
AZT-MP in PBS and HEPES may be due to the iron-
chelating properties of the phosphate buffer. Interestingly,
the prooxidant effect of AZT and AZT-MP in phosphate
buffer can be completely suppressed by adding magnesium
salts in concentrations comparable to normal physiological
levels, which may be due to the well-known stabilizing effect
of magnesium on iron-catalyzed decomposition of H2O2
[25]. Furthermore, it also suggests that hypomagnesemia
may promote a prooxidant effect of AZT. Peak plasma
concentrations of AZT can reach levels as high as 54 AM
[26] (human studies, oral doses of AZT 15 mg/kg every 4 h),
whereas urinary AZT levels have been reported to reach
concentrations as high as 370 AM [27] (rhesus monkeys, one
subcutaneous dose of AZT 33.3 mg/kg). Thus, the in vitro
AZT concentrations with a prooxidant effect are comparableto AZT levels found in HIV patients. In addition, the
localized concentrations of AZT and AZT phosphates within
tissue may also reach prooxidant levels. Furthermore, one
should note that AZT-TP typically achieves levels inside the
cell not greater than 1 AM [28], whereas AZT-MP can reach
an intracellular concentration around 0.1 mM [29]. There-
fore, AZT-TP should not significantly contribute to the
prooxidant activity of AZT. Intracellular concentrations of
AZT-MP have been shown to increase in patients with low
CD4+ lymphocyte counts, which could have toxicological
implications [30].
The lack of change in redox activity for AZT phosphates
compared to AZT (Fig. 4A) may be attributed to the poor
iron-chelating properties of AZT phosphate derivatives at
neutral pH [28]. It has been reported earlier that di- and
triphosphate adenine-nucleotides inhibit Fe2 + autoxidation
and deoxyribose damage in Na phosphate buffer at pH 7.4
due to the formation of Fe2 +-nucleotide complex [31]. This is
contrary to our observation for AZT phosphates and may be
due to much weaker iron-chelating properties of AZT phos-
Fig. 5. Redox properties of AZT catabolites. Concentration-dependent
effects of the AZT metabolites 3V-amino-3V-deoxythymidine (AMT, A) and
AZT-h-D-glucuronide (GAZT, B) on DCDHF oxidation in 100 mM PBS
(., pH = 7.4) and 100 mM HEPES buffer (o, pH = 7.4). Test conditions
include 50 AM DCDHF, 2.0 mM H2O2 and 20 AM FeSO4 and the
absorbance of the oxidation product DCF is measured at 500 nm. Relative
absorbance is calculated as the ratio in absorbance with and without AMT
or GAZT. All values are reported as meansF S.E. of three to seven separate
determinations.
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ylation in lymphocytes is quantitatively a minor pathway,
accounting for less than 1% of its transformation [30].
3.3. Redox properties of AZT catabolites
The predominant pathway of AZT metabolism is glucur-
onidation to GAZT (up to 80% of the drug in humans), which
is excreted with urine [26]. GAZT plasma levels in patients
are typically two to three times greater than the AZT
concentrations [26] and the levels of GAZT in urine could
reach up to 0.86 mM [27] (rhesus monkeys, one subcutane-
ous dose of AZT 33.3 mg/kg). A number of drugs co-
administered with AZT have been shown to inhibit AZT
glucuronidation [30]. AMT is a cytotoxic AZT metabolite,
derived by the reduction of the azido moiety to amino group
[32]. Peak concentrations of AMT in HIV patients can reach
approximately 10–15% of the AZT circulating in the plasma
[30]. Interestingly, AMT (400 AM–2.0 mM) acted as an
antioxidant in phosphate buffer and had no effect in HEPES
(Fig. 5A). At the same time, GAZT exhibited a prooxidant
effect in the phosphate buffer (400 AM–1.0 mM GAZT) and
HEPES (400 AM–2.0 mM GAZT) (Fig. 5B). Again, the
difference in redox properties of AMT and GAZT in PBS
versus HEPESmay be a result of the iron-chelating properties
of the phosphate groups.
Compounds related to AZT such as thymidine (3V-deox-
ythymidine), thymine, 2-deoxyribose, 2-deoxyribose 5-
phosphate and azide were also tested using the same dichlor-
ofluorescin assay. Thymidine had no effect in concentrations
up to 6.0 mM, whereas thymine (100 AM–1.0 mM) and 2-
deoxyribose and 2-deoxyribose 5-phosphate (100 AM–1.0
mM) acted as antioxidant in the PBS (data not shown).
Deoxyribose is a well-known scavenger of hydroxyl radical
(SOH) reacting with SOH with a rate constant of 3.1109
M 1 s 1 to yield malonaldehyde [33]. Only azide has
shown a significant prooxidant activity in dichlorofluorescin
assay (400% yield of DCF at azide concentrations of 1mM
and higher) in the phosphate buffer. Azide is known to form
a strong one-electron oxidant—azidyl radical (N3˙) in the
presence of H2O2 and iron complexes [34]. One may note
also that in the dichlorofluorescin assay only azido-contain-
ing derivatives of 3V-deoxy-thymidine (AZT, AZT-MP, AZT-
TP and GAZT) have shown prooxidant effects, whereas
AMT and thymidine have not demonstrated prooxidant
activity. Furthermore, the presence or absence of the phos-
phate groups in AZT derivatives has not affected the proox-
idant activity of these compounds. AZT can potentially form
a number of other free radical species in the presence of
hydroxyl radical. The literature contains evidence that the
thymine and deoxyribose components of AZT can form free
radicals following gamma-irradiation-induced SOH expo-
sure. Six different thymine radicals (carbon-centered and
peroxyl) and two different ribose sugar radicals (carbon-
centered) were detected by electron paramagnetic resonance
spectroscopy at 77 K [35]. It remains to be seen if any ofthese radicals can be produced from the AZT molecule under
conditions of oxidative stress.
Interestingly, prooxidant effects have been reported for
nucleoside analogs other that AZT [12]. Structural simi-
larity between NRTIs suggests that all these drugs may
be redox active. This paper demonstrates that AZT (in
clinically relevant concentrations) exhibits direct proox-
idant activity, or enhances oxidative potential of macro-
phages following activation of NADPH-oxidase. This
latter pathway may be particularly important in HIV-
patients with secondary infections.Acknowledgements
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